Mild or asymptomatic infections with the SARS coronavirus-2 are often not detected. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. The...
In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the...
The Royal Swedish Academy of Sciences has awarded this year’s Nobel Prize in Chemistry to Emmanuelle Charpentier, former Head of the Department “Regulation in Infection Biology” at the Helmholtz Centre for Infection...
Even though we have been living with the COVID- pandemic for more than half a year, there are still many unanswered questions and major uncertainties regarding further infection. How will the epidemic develop in Germany...
Many SARS-coronavirus-2 infections are mild or completely asymptomatic and are therefore not detected. This makes it difficult to assess pandemic trends, prevention strategies and mortality rates. Antibody studies can...
The European Research Council (ERC) awards three scientists from the Helmholtz Centre for Infection Research (HZI) with an ERC Starting Grant. The grants of up to 1.5 million Euros over a period of five years will be...
Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for...
The new consortium CARE (Corona Accelerated R&D in Europe), supported by the Innovative Medicines Initiative (IMI) public-private partnership, announced its launch today to accelerate the discovery and development of...
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and...
